Skip to content

EV / sales at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
2.7×-1.4×
Stryker logo
StrykerSYK
5.4×-1.3×
IAR
Integra LifeSciencesIART
1.5×-0.6×
Solventum logo
SolventumSOLV
-0.5×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
0.7×-0.2×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
7.3×-2.6×

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

Based on the most recent quarter.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s EV / sales?
Sanara MedTech Inc. (SMTI) reported EV / sales of 1.8× in Q1 2026.
How has Sanara MedTech Inc.'s EV / sales changed year-over-year?
Sanara MedTech Inc.'s EV / sales decreased by 45.2% year-over-year, from 3.3× to 1.8×.
What is the long-term trend for Sanara MedTech Inc.'s EV / sales?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s EV / sales has grown at a -33.8% compound annual growth rate (CAGR), from 18.3× to 2.3×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.